ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand. The company also offers dermal tissue product, a deep dermal product used in the repair of reconstructive and cosmetic surgical cases; and amniotic tissue product ranges used to aid the healing of wounds under the Empliq brand. In addition, it provides Nerve Conduit Range, a nerve conduit designed to facilitate nerve growth over short gaps between nerve ends; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries, but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand that are in development phase. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
Price analytics
Returns
1 day
5.0%
1 week
13.5%
1 month
9.1%
3 months
6.3%
6 months
-16.0%
1 year
-40.0%
3 years
—
Risk
Volatility (1y ann.)
98.5%
Beta vs ASX 200
-0.01
Sharpe (1y)
-0.13
VaR 95% (1-day)
-6.8%
Max drawdown (1y)
-61.1%
Off 1-year high
-52.0%
Technicals
RSI(14)
75
OB
vs 50DMA
10.0%
vs 200DMA
-7.6%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value58.1
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
46
Price / Sales
0
Growth100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum32.1
6-month return vs ASX 200
7
Price vs 200-day average
25
Price vs 50-day average
100
Position in 52-week range
10
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).